Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Snapdragon Chemistry
Snapdragon Chemistry
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Cambrex completes Snapdragon Chemistry acquisition
The company continues to expand its portfolio of specialised solutions for pharmaceutical development and manufacturing
Manufacturing
Cambrex set to acquire Snapdragon Chemistry
“The acquisition of Snapdragon will accelerate our growth in the area of continuous flow process development and manufacturing"
Manufacturing
Asymchem acquires US-based Snapdragon Chemistry
“We believe continuous flow manufacturing… represents the future of pharmaceutical production,” said Dr Hao Hong, Chair & CEO of Asymchem
Manufacturing
Asymchem and Snapdragon enter global partnership
The investment partnership has provided funding for Snapdragon to complete its expansion plan to build cGMP drug substance manufacturing suites
Subscribe now